Replies to post #103543 on Biotech Values

[RockRat]

Indeed. It turns out Teva examined documents produced by Sandoz during discovery and subsequently dropped the trade secrets issue last November. Those were counts IX and X as noted in the docket item 88.

Regards, RockRat